ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 451 • 2016 ACR/ARHP Annual Meeting

    Cross-Sectional and Longitudinal Construct Validity for the Improved Health Assessment Questionnaire Among Adults with Knee Osteoarthritis

    Mei Chung1, Augustine C. Lee2, John B. Wong3, Xingyi Han4 and Chenchen Wang2, 1Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, 2Rheumatology, Tufts Medical Center, Boston, MA, 3Tufts Medical Center, Boston, MA, 4Public Health and Community Medicine, Tufts University, Boston, MA

      Background/Purpose: The improved Health Assessment Questionnaire (iHAQ) is a novel version of the HAQ (ACR-recommended metric of physical function for RA) based on Item…
  • Abstract Number: 452 • 2016 ACR/ARHP Annual Meeting

    The Efficacy of Motivational Counselling and SMS-Reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis: A Randomised Controlled Trial

    Tanja Thomsen1, Mette Aadahl2, Nina Beyer3, Merete Lund Hetland4, Katrine Loeppenthin1, Julie Midtgaard5, Robin Christensen6, Mikkel Østergaard7, Poul Jennum8 and Bente Appel Esbensen1, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 2Research Centre for Prevention and Health, Rigshospitalet, Denmark, Copenhagen, Denmark, 3Musculoskeletal Rehabilitation Research Unit, Bispebjerg and Frederiksberg Hospitals, Denmark, Copenhagen, Denmark, 4Danish Rheumatologic Biobank and DANBIO registry, Rigshospitalet, Glostrup, Gentofte and Herlev University Hospital, Copenhagen, Denmark, 5University Hospitals Centre for Health Research, Rigshospitalet, Copenhagen, Denmark, 6Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, 7Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark, 8Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Rigshospitalet, Denmark, Copenhagen, Denmark

    Background/Purpose:  Patients with rheumatoid arthritis (RA) are more sedentary than the general population, which can have serious health consequences. Reducing sedentary behaviour (SB) and increasing…
  • Abstract Number: 453 • 2016 ACR/ARHP Annual Meeting

    Adaptation and Validation the Systemic Sclerosis Quality of Life Questionnaire into Spanish Using Rasch Analysis

    Mwidimi Ndosi1, Silvia Garcia-Diaz2, Begonya Alcacer-Pitarch3, Francesco Del Galdo4, Vicenç Torrente-Segarra2 and Anthony C. Redmond4, 1Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 2Rheumatology, Hospital Sant Joan Despí Moisès Broggi-CSI-, Barcelona, Spain, 3Leeds Institute of Rheumatic and Musculoskeletal medicine, University of Leeds, Leeds, United Kingdom, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Systemic Sclerosis (SSc) represents a group of heterogeneous autoimmune disorders of connective tissue characterized by progressive fibrosis of the skin and internal organs [1].…
  • Abstract Number: 455 • 2016 ACR/ARHP Annual Meeting

    Validity, Reliability and Sensitivity to Change of Four Different Patient-Reported Outcomes (PROs) to Measure the Domains Pain, Fatigue, Experienced Disease Activity and General Well-Being in Patients with Rheumatoid Arthritis

    Lisanne Renskers1, Piet L.C.M. van Riel2,3 and Ron J.J.C. van Uden1, 1IQ healthcare, Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, 2Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, 3Bernhoven, Department of Rheumatology, Uden, Netherlands

    Background/Purpose: With Patient-Reported Outcomes (PROs), the patient's perspective can be assessed. Several forms can be used; Verbal Rating Scale (VRS), Numerical Rating Scale (NRS), Visual…
  • Abstract Number: 456 • 2016 ACR/ARHP Annual Meeting

    Patient Engagement in Research: Understanding Patient Interest and Needs

    Jennifer R. Horonjeff1, Emily L. Creek2 and Cindy McDaniel3, 1Rheumatology, Columbia University Medical Center, New York, NY, 2Consumer Health, Arthritis Foundation, Atlanta, GA, 3Arthritis Foundation, Atlanta, GA

    Background/Purpose: The goal of clinical and health-related research is to benefit the end-consumer—the patient. Since patients are the experts on their unique experiences living with…
  • Abstract Number: 457 • 2016 ACR/ARHP Annual Meeting

    Novel Mechanism Mediated By the IL-23/Th17 Axis Contributing to Auto-Immune Arthritis

    René Pfeifle1, Tobias Rothe1, Natacha Ipseiz1, Stephan Culemann1, Ulrike Harre2, Gerhard Krönke3 and Georg Schett4, 1Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany, 3Universitätsklinikum Erlangen, Erlangen, Austria, 4Department of Internal Medicine III, Institute for Clinical Immunology,, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany

    Background/Purpose: Checkpoints and mechanisms regulating the onset of rheumatoid arthritis (RA) remain largely elusive. Apart from B cells and auto-antibodies, Th17 cells were shown to…
  • Abstract Number: 458 • 2016 ACR/ARHP Annual Meeting

    The TAM Receptors Axl and Mer Play a Protective Role in a Temporal and Spatial Manner in Inflammatory Arthritis

    Claire E.J. Waterborg1, Paqui G. Través2, Silke Beermann1, Marije I. Koenders1, Greg Lemke2 and Fons A.J. van de Loo1, 1Experimental Rheumatology, Radboudumc, Nijmegen, Netherlands, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA

    Background/Purpose:  Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an unrestrained inflammatory response in selective, anatomically distinct synovial joints. The innate immune system…
  • Abstract Number: 459 • 2016 ACR/ARHP Annual Meeting

    Resident Non-Classical Monocytes Are Critically Important for Tissue Destruction in Arthritis

    Antonia Puchner1, Victoria Saferding2, Michael Bonelli3, Carl-Walter Steiner2, Eliana Goncalves-Alves3, Silvia Hayer4, Yohei Mikami5, Marije M. Koenders6, Birgit Niederreiter7, Josef S. Smolen8, Kurt Redlich3, Stephan Blüml9 and Michael Bonelli and Stephan blueml, 1Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Rheumatology, Medical University of Vienna, Vienna, Austria, 3Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 4Waehringer Guertel 18-20 A-A09, Medical University of Vienna, Vienna, Austria, 5Molecular Immunology and Inflammation Branch, NIAMS, Bethesda, MD, 6Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 7Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria, 8Medical University of Vienna, Vienna, Austria, 9Internal Medicine 3; Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Bone destruction in rheumatoid arthritis is mediated by osteoclasts, which are derived from precursor cells of the myeloid lineage. Although there is much known…
  • Abstract Number: 460 • 2016 ACR/ARHP Annual Meeting

    TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Demonstrates Anti-Inflammatory Effect in Autoimmune Disease Models

    Yohei Yoshiga1, Fumihito Hosoi1, Satoru Iguchi1, Ryuusuke Kaneko1, Yoshinori Nakachi1, Daichi Akasaka1, Kenji Tanaka2, Kazuhiko Yonekura2, Teruhiro Utsugi2, Eiji Sasaki2 and Yoshikazu Iwasawa2, 1TAIHO PHARMACEUTICAL CO., LTD., TSUKUBA, Japan, 2TAIHO PHARMACEUTICAL CO., LTD., Tsukuba, Japan

    Background/Purpose:  Bruton’s Tyrosine Kinase (BTK), a non-receptor tyrosine kinase is involved in intracellular signaling pathways downstream of several receptors, including the B cell receptor (BCR),…
  • Abstract Number: 461 • 2016 ACR/ARHP Annual Meeting

    Involvement of CD163-Positive Macrophages in the Pathogenesis of Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Synovium of a Murine Model

    Shinjiro Kaieda1, Hiroaki Ida2 and Tomoaki Hoshino3, 1Department of Medicine, *Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, kurume, Japan, 2Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 3Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan

    Background/Purpose:  Synovial-lining macrophages play a crucial role in the onset and maintenance of joint inflammation in arthritis. CD68 and CD163 are commonly used markers of…
  • Abstract Number: 462 • 2016 ACR/ARHP Annual Meeting

    Selective Inhibition of MMP9 Using a Monoclonal Antibody As a Therapeutic Strategy for Rheumatoid Arthritis

    Sunhwa Kim1, Brian Carr1, Leah Tong1, Debi Jin1, Ruth Wang1, Derrek Marshall1, David Gossage2 and Victoria Smith1, 1Biology, Gilead Sciences, Inc., Foster city, CA, 2Biology, Gilead Sciences, Inc., foster city, CA

    Background/Purpose: Matrix metalloproteinase-9 (MMP9), highly expressed by infiltrating inflammatory cells, pannus tissue, and multinucleated cells in the synovium and subchondral bone tissue, including osteoclasts, participates…
  • Abstract Number: 463 • 2016 ACR/ARHP Annual Meeting

    Deficiency of Transmembrane Protein VISTA (V-domain Immunoglobulin Suppressor of T-cell Activation) Ameliorates Murine Collagen-II Antibody-Induced Arthritis

    Roy Fava1,2, Sabrina Ceeraz3, Susan Eszterhas4, Petra Sergent3, Christopher Burns5 and Mathew Vincenti6,7, 1Research, Department of Veterans Affairs, White River Junction, VT, 2Department of Medicinee, Geisel School of Medicine at Dartmouth, Lebanon, NH, 3Microbiology/Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, 4Research, Department of Veterans Affairs, white River Junction, VT, 5Section of Rheumatology, Geisel School of Medicine at Dartmouth, Lebanon, NH, 6Department of Veterans Affairs, White River Junction, VT, 7Department of Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH

    Background/Purpose: The transmembrane protein VISTA, is a member of the B7/CD28 family of immune modulator proteins and can function as a negative immune checkpoint regulator…
  • Abstract Number: 464 • 2016 ACR/ARHP Annual Meeting

    an Anti-Fima Antibody Attenuates Porphyromonas Gingivalis-Associated Experimental Arthritis

    Sang Hoon Jeong1, Jennifer Lee2, Seo Hwa Kim3, Haneul Kim4, Seung-Ki Kwok5, Sung-Hwan Park6 and Ji Hyeon Ju7, 1The Catholic University of Korea, Seoul, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of, 3Division of Rheumatology,, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, 4Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, 5[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 6Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 7Division of Rheumatology, Department of Internal Medicine,, College of Medicine, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose:  Evidence suggests that periodontal infection by Porphyromonas gingivalis(Pg) exacerbates rheumatoid arthritis (RA); however, the underlying mechanisms remain unknown. Here, we examined the pathogenic and therapeutic…
  • Abstract Number: 465 • 2016 ACR/ARHP Annual Meeting

    Genetic and Metabolic Signatures of Purified Synovial Macrophage Subsets during an Acute Murine Model of Inflammatory Arthritis

    Philip J. Homan1, Harris R. Perlman2 and Carla Cuda3, 1Medicine-Rheumatology, Northwestern University, Chicago, IL, 2Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL

    Background/Purpose: Rheumatoid arthritis (RA) manifests in persistent synovial inflammation, cellular infiltration and pro-inflammatory cytokine production, and results in progressive joint destruction. Macrophages have been implicated in…
  • Abstract Number: 466 • 2016 ACR/ARHP Annual Meeting

    Sexually Dimorphic Dysbiosis of Gut Microbiota in Tumor Necrosis Factor Transgenic Mice with Inflammatory-Erosive Arthritis

    Richard Bell1,2, Ronald Wood3, Christopher T. Ritchlin4, Edward Schwarz5 and Homaira Rahimi6, 1Center for Musculoskelatal Research, University of Rochester, Rochester, NY, 2Pathology, University of Rochester, Rochester, NY, 3University of Rochester, Rochester, NY, 4Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY, 5Orthopedeatrics, University of Rochester, Rochester, NY, 6Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Recent studies identify gut microbiota dysbiosis as a possible contributor to rheumatoid arthritis (RA) pathogenesis. RA patients have significantly different microbiomes than healthy controls.…
  • « Previous Page
  • 1
  • …
  • 1446
  • 1447
  • 1448
  • 1449
  • 1450
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology